Diagnostic Imaging Market By Modality (X-ray Imaging, Computed Tomography - CT, Magnetic Resonance Imaging - MRI, Ultrasound Imaging, Nuclear Imaging, Mammography, Fluoroscopy), By Application (Oncology, Cardiology, Neurology, Orthopedics, Obstetrics & Gynecology, Gastroenterology, Others), By Technology (Digital Imaging, Analog Imaging, Hybrid Imaging, Point-of-care Imaging, AI-enabled Imaging Systems), By Portability (Fixed Systems, Mobile Systems, Handheld Devices), By End User (Hospitals, Diagnostic Imaging Centers, Ambulatory Surgical Centers, Specialty Clinics, Research & Academic Institutes), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

---

What trends will shape Diagnostic Imaging Market in the coming years?

The Diagnostic Imaging Market accounted for USD 48.21 Billion in 2024 and USD 50.58 Billion in 2025 is expected to reach USD 81.68 Billion by 2035, growing at a CAGR of around 4.91% between 2025 and 2035. The diagnostic imaging market applies to the industry engaged in the development, manufacture, and sale of medical imaging devices utilised in the diagnosis of diseases and in monitoring the health of a patient. Technologies that fall in this market are X-rays, MRI (magnetic resonance imaging), CT (computerised tomography) scans, ultrasound, and nuclear testing. They assist medics in examining the inside of the body in a non-invasive manner. The drivers in the market include innovations in imaging technology, increasing the rates of chronic illnesses, and the demand for early and accurate diagnosis. The spread in healthcare infrastructure and awareness also helps in growing it worldwide.

What do industry experts say about the Diagnostic Imaging market trends?

“Diagnostic imaging is the cornerstone of modern medicine, enabling early detection, precise diagnosis, and personalized treatment planning across almost all disease areas.”

• Dr. Hedvig Hricak, MD, PhD – Chair, Department of Radiology, Memorial Sloan Kettering Cancer Center

“Advancements in diagnostic imaging, particularly in MRI and CT technologies, have significantly improved diagnostic accuracy while reducing patient risk through lower radiation doses.”

• Dr. James P. Borgstede, MD – Former Chair, Board of Chancellors, American College of Radiology

Which segments and geographies does the report analyze?

What are the key drivers and challenges shaping the Diagnostic Imaging market?

In what ways does rising chronic disease prevalence fuel imaging demand?

The increasing frequency of chronic diseases (like cancer, cardiovascular diseases, diabetes, and respiratory diseases) increases the number of people who need diagnostic imaging. Chronic conditions frequently need regular checks and early diagnostics to determine the development of this or that medical condition and to monitor the complications and manage them. That is why such types of imaging as MRI, CT scans, and ultrasound are used more frequently.

Chronic diseases are estimated to cause about 71% of all deaths around the world, according to the World Health Organisation, making diagnostic tools quintessential in the management of these conditions. Chronic diseases are also reported to be prevalent in about 6 out of 10 adults in the United States alone, making constant diagnostic assessments necessary.

The world is getting older, and the load of chronic illnesses is increasing the need for imaging technologies by healthcare providers to ensure that they provide accurate diagnosis and treatment planning. The given trend can be explained by the increasing governmental healthcare programmes aimed at timely diagnosis and prevention, which directly contribute to the growth of the diagnostic imaging market.

Can expanding healthcare infrastructure globally increase diagnostic imaging adoption rates?

The implementation of healthcare infrastructure in the world, especially in developing countries, boosts the level of adoption of diagnostic imaging greatly. Better medical facilities enhance access to such high-tech scanning instruments as MRI, CT, and ultrasound, particularly in the underdeveloped world, where the availability of diagnostic tools is restricted. The World Health Organisation (WHO) estimated that more than half of the low-income countries did not possess basic imaging and that there was significant growth potential since the infrastructure would improve.

According to the U.S. National Institutes of Health (NIH), improved rates of early disease detection tend to escalate in proportion to the investment level in healthcare infrastructure, which is highly dependent on the use of imaging equipment. Accordingly, to close this disparity in diagnostic imaging adoption in diverse parts of the world, developing infrastructure is critical to ensuring that critical medical diagnoses can be made in a timely and accurate manner to enhance patient outcomes.

Could stringent government regulations slow down market growth significantly?

Strict government regulations will definitely affect the growth of the diagnostic imaging market by adding costs in the process of compliance and delaying the approval of new technologies. Regulatory organisations like the U.S. Food and Drug Administration (FDA) demand high-quality standards to make sure that imaging devices are safe to use, which usually necessitates tedious clinical trials and paperwork prior to an imaging device entering the market. As the FDA stated, it takes anything between a few months and a full year on average to run the approval of a medical device, hindering product launches and innovation periods.

The pending regulations vary geographically, thus making international expansion challenging and increasing risks to the manufacturer. It is also noted by the National Institutes of Health (NIH) that the efficiency and safety criteria must be adhered to, even though it may pose a challenge to the smaller companies due to a lack of resources, which affects the overall growth of the market. Such regulations, though essential in protecting the health of the population, tend to delay the levels of more rapid commercialisation and hence slow down the market development in the field of diagnostic imaging.

What role does emerging economies’ healthcare modernization play in market expansion?

The modernisation of healthcare in emerging economies is an important factor that will help in expanding the diagnostic imaging market because it will stimulate demand for advanced medical technologies. Innovations like high technology in healthcare are being implemented by governments in India, Brazil, and China to raise healthcare budgets and invest in infrastructure to increase the ability to detect diseases at an early stage and ensure better results in treating people. With an average rate of 6 per cent annual growth in healthcare spending witnessed in the last 10 years, according to World Health Organisation statistics, diagnostic tools have gained access to a wider range of people in low- and middle-income countries.

Projects and policies like the National Health Policy 2017 in India specifically have been focusing on improving diagnostic care, so the use of imaging complications (MRI, CT, and ultrasound) is also gaining traction. This modernisation expands patient numbers and paves the way to collaboration between the private and public sectors, hence stimulating the market expansion. These countries will also emphasise the quality of their healthcare services and their accessibility. This aspect is expected to drive the growth of escalated diagnostic equipment, and emerging markets are also the assumed growth engines of the market.

How might artificial intelligence integration revolutionize diagnostic imaging procedures?

Artificial intelligence (AI) applications are transforming diagnostic imaging to make it more precise, faster, and efficient in the decision-making process. Machine-learning algorithms aid radiologists in identifying abnormalities, like tumours and lesions, in a more precise way, eliminating the errors of the human observer and enhancing early diagnosis.

The National Institutes of Health (NIH) further adds that imaging using AI has proven over 90% accuracy level in diagnosing diseases such as breast cancer and pneumonia detection. It also facilitates the workflow through automating such routine activities as segmentation of images and production of a report, and healthcare professionals spend more time looking after their patients.

The Food and Drug Administration (FDA) has cleared several AI-based diagnostic methods, which highlights the clinical viability of the technology. As diagnostic imaging is becoming more and more important, due to the increasing demand for speed and accuracy, AI is one of the most promising innovations in terms of patient outcomes and cost savings, through timely intervention and preventative tests.

What are the key market segments in the Diagnostic Imaging industry?

Based on the Modality, the Diagnostic Imaging Market is classified into X-ray Imaging, Computed Tomography, Magnetic Resonance Imaging (MRI), Ultrasound Imaging, Nuclear Imaging, Mammography, and Fluoroscopy.Computed Tomography (known as CT) is the most prominent in the diagnostic imaging market among the various modalities. CT imaging is an excellent means of providing cross-sectional images of the body in detailed and rapid snapshots, and as such, it is useful in diagnosing a myriad of conditions such as trauma, cancer, and the like. Its capacity to offer high-resolution images that offered good contrast between distinct tissues prompted the commercialisation of the technology in almost all hospitals and clinics. The invention of improved technology in CT, e.g., low-dose and faster scanning protocols, is widening its scope of use and market dominance.

Based on the application, the Diagnostic Imaging Market is classified into Oncology, Cardiology, Neurology, Orthopedics, Obstetrics & Gynecology, Gastroenterology, and Others. The largest segment in the oncology application market in the diagnostic imaging market is oncology. This is because imaging holds the predominant role in the detection, staging, treatment planning, and response evaluation of cancer. As females develop tumours and seek the opinions of doctors, advanced scanning tools like CT, MRI, and PET scans are critical in determining the tumour and the extent to which it has spread, allowing for custom treatment measures. Oncology Image-Guided Therapy Oncology imaging continues to add significant weight to the market as a rise in cancer prevalence spikes the need to diagnose the disease early and correctly.

Which regions are leading the Diagnostic Imaging market, and why?

The North American diagnostic imaging market is growing due to several factors. The region has deployed the best healthcare infrastructure, prevalence of state-of-the-art imaging technologies, and high levels of medical research and development investments. Chronic diseases are highly prevalent worldwide (cancer and cardiovascular diseases included), creating a demand for proper and early diagnostics. There is also a high reimbursement policy and availability of major manufacturers of imaging equipment, which leads to market growth. There is also a growing body of knowledge among patients and healthcare professionals regarding the value of early diagnoses and, therefore, adoption.

Further, it is also leading in the North American market due to its incorporation of technological advancements, such as AI implementation and handheld imaging devices. The region is also quite competitive when it comes to quicker registration and implementation of the new imaging technologies in view of its well-developed regulatory system. Finally, an increase in healthcare costs and the ageing population is leading to growth in demand for diagnostic imaging cases.

The Asia Pacific diagnostic imaging market is growing due to several factors. The rise in the population and the influx of chronic disorders such as cancer and cardiovascular diseases are boosting the demand for advanced imaging technologies. Furthermore, healthcare spending is increasing, and governments are taking steps to enhance the healthcare infrastructure, hence boosting market expansion. Highly skilled medical workers and awareness of early diagnosis and treatment are also assets in the region.

The high rate of rapid urbanisation of nations and the technological changes incorporated, such as the applications of AI and portable imaging devices, are additional factors that reinforce the market. Additionally, nations such as China, India, and Japan also spend a lot on healthcare innovation, meaning the Asia Pacific is at the spearhead of diagnostic imaging.

Affordable diagnostic equipment and the growing number of healthcare units in the private sector are also factors that lead to growth and expansion in the market. Further, the increasing convergence between the local and global companies is fast-tracking the entry of innovative imaging solutions in the market.

What does the competitive landscape of the Diagnostic Imaging market look like?

The diagnostic imaging market is highly competitive, moving around world leaders like General Electric, Siemens Healthineers, Philips Healthcare, Canon Inc., and Fujifilm Holdings Corporation. One way is the continuous investment by these companies in advanced technologies such as integrating AI, deploying cloud-based imaging solutions, and improving imaging modalities to retain their market leadership. New trends in AI-enhanced imaging software usability are launched by Siemens Healthineers to support the diagnostic efficiency and workflow of potential patients, and the GE Healthcare product line is extended by having innovations in portable imaging systems to enhance penetration rates.

Philips Healthcare has consolidated its presence in the cardiovascular imaging sector by entering into strategic alliances and product upgrades. Further, new entrants such as Mindray and Neusoft are starting to gain market share in Asia due to low-cost solutions. The growing competition in this market can be attributed to the presence of innovative technology, the increasing need for non-invasive diagnostics, and the development of healthcare facilities across the world.

Diagnostic Imaging Market, Company Shares Analysis, 2024

To explore in-depth analysis in this report - Request Sample Report

Which recent mergers, acquisitions, or product launches are shaping the Diagnostic Imaging industry?

• In March 2025, Canon Medical Systems USA announced FDA 510(k) clearance and U.S. launch of the Adora DRFi system. The hybrid radiography and fluoroscopy unit featured a rotating ceiling setup with independently moving arms. It used PositionAnywhere technology to adjust to the patient’s position.
• In January 2025, Philips launched the AI-enabled CT 5300 as part of its Smart Imaging portfolio. The CT 5300 included AI tools for image reconstruction, cardiac motion correction, and workflow efficiency. Philips also showcased its BlueSeal wide-bore MRI, using only 0.5% of the helium required by conventional magnets.

Report Coverage:

By Modality

• X-ray Imaging
• Computed Tomography (CT)
• Magnetic Resonance Imaging (MRI)
• Ultrasound Imaging
• Nuclear Imaging
• Mammography
• Fluoroscopy

By Application

• Oncology
• Cardiology
• Neurology
• Orthopedics
• Obstetrics & Gynecology
• Gastroenterology
• Others

By Technology

• Digital Imaging
• Analog Imaging
• Hybrid Imaging
• Point-of-care Imaging
• AI-enabled Imaging Systems

By Portability

• Fixed Systems
• Mobile Systems
• Handheld Devices

By End User

• Hospitals
• Diagnostic Imaging Centers
• Ambulatory Surgical Centers
• Specialty Clinics
• Research & Academic Institutes

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of Middle East & Africa

List of Companies:

• General Electric
• Siemens AG
• Koninklijke Philips N.V.
• Canon Inc.
• Fujifilm Holdings Corporation
• Samsung Electronics
• Hologic, Inc.
• Hitachi, Ltd.
• Carestream Health
• Shimadzu Corporation
• Mindray Medical International
• Esaote SpA
• Neusoft Corporation
• DMS Imaging
• Esaote SpA

Frequently Asked Questions (FAQs)